A Survival God for the Age of Abundance,” Peter H. Diamandis and Steven Kotler explore what it means to be human in a world ...
A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...
The company described the round as fully subscribed and said the cash should keep operations running into the second half of ...
India, April 13 -- Life Biosciences, a clinical-stage biotechnology company focused on reversing diseases of aging, has ...
Lactate, once considered a metabolic waste product, is now recognized as a key regulator of cellular homeostasis and disease progression. In gynecological malignancies-including ovarian, cervical, and ...
A startup cofounded by a renowned Harvard geneticist has taken a step toward cracking the human body’s biological breakdown by securing FDA approval to test its cutting-edge gene therapy on humans.
Kazia Therapeutics Limited (Nasdaq: KZIA), a clinical-stage oncology company advancing therapies to reprogram cancer biology and overcome treatment resistance, announces the in-licensing of a first-in ...
Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results